CD86 and COVID-19: To explore whether the monocytes from COVID-19 patients exhibit a similar phenotype, we evaluated the expression levels of several activation markers, including CD33, CD86, CD80, HLA-DR, and CD40, in monocytes isolated from the peripheral blood mononuclear cells (PBMCs) of HD, MP and SP group.